Volume 28, Supplement—December 2022
SUPPLEMENT ISSUE
Clinical
Past as Prologue—Use of Rubella Vaccination Program Lessons to Inform COVID-19 Vaccination
Meredith G. Dixon
, Susan E. Reef, Laura A. Zimmerman, and Gavin B. Grant
, Susan E. Reef, Laura A. Zimmerman, and Gavin B. Grant
Table 2
Comparison of the 2 strategies used for rubella control and elimination activities*
| Comparator | Individual protection strategy | Universal strategy |
|---|---|---|
| Strategic target | High-risk individuals | Susceptible population |
| Populations | Women of child-bearing age | Infants and campaigns targeting susceptible individuals |
| Initial goals | Reduce cases of CRS | Elimination of rubella and CRS |
| Strategy used when | Low infant vaccination coverage; concerns for safety | High infant vaccination coverage (>80%) |
| Monitoring systems | Surveillance for CRS; rubella vaccination coverage; special surveys/studies | Surveillance for rubella and CRS; rubella vaccination coverage; special surveys and studies |
| Examples | Initial United Kingdom strategy; initial global (WHO) strategy | Initial United States strategy; current global (WHO) strategy |
*CRS, congenital rubella syndrome; WHO, World Health Organization.
Page created: August 12, 2022
Page updated: December 11, 2022
Page reviewed: December 11, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.